MPM Oncology Impact Management GP LLC

Insider Buys Quantity –

Sector

Industry

Transaction Type

Transaction Date

Total Value


2017-11-06	Purchase	Viracta Therapeutics, Inc. VIRX	10 percent owner	16,200 0.0629%	$2.77	$44,874	-10.31%
2017-11-03	Purchase	Viracta Therapeutics, Inc. VIRX	10 percent owner	40,000 0.1572%	$2.89	$115,600	-12.67%
2017-11-02	Purchase	Viracta Therapeutics, Inc. VIRX	10 percent owner	25,300 0.1009%	$2.59	$65,527	-0.94%